DKK2 and cancer: Thus, the availability of recombinant DKK2 would facilitate the understanding of its regulation and dysregulation in ischemic vascular diseases [13], and angiogenesis-dependent tumor growth and metastasis [14,15,16,17,18,19] contributing to the treatment of cancer [20,21].